COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations' Licensed PNKP Inhibitor Technology Shown to Increase Sensitivity of Cancer Cells to Radiation in Animal Study
Onco-Innovations Limited introduces exclusive PNKP inhibitors to enhance sensitivity of cancer cells to radiation, potentially revolutionizing targeted cancer treatments -
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Announces Expression of Interest Between Inka Health and Global Data Leader, Quantify Research
Onco-Innovations announces Expression of Interest with Quantify Research, a global healthcare data analytics leader, to explore collaborations in advanced data analytics and oncology research -
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Completes Acquisition of Inka Health to Accelerate AI-Driven Cancer Research and Drug Development
Onco-Innovations Limited completes acquisition of Inka Health Corp, a Canadian-based software company pioneering AI-driven analytics in cancer research and drug development. Strengthens precision oncology capabilities
